ClinicalTrials.Veeva

Menu
S

St. Hope Foundation | Bellaire Health Center - Research Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

E/C/F/TAF
Bictegravir
Lenacapavir
Tenofovir Alafenamide
Nucleos(t)Ide
TAF
GS-3242
BMS-986001
Emtricitabine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 6 total trials

A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1

The study will have two parts: Part A and Part B. In Part A, the goal of the study is to compare the effectiveness of switching to the study drugs GS...

Enrolling
HIV-1-infection
Drug: Lenacapavir Injection
Drug: GS-3242 Injection
Locations recently updated

The goal of this clinical study is to learn more about the effects of switching to the study drugs, bictegravir (BIC) plus lenacapavir (LEN), versus...

Active, not recruiting
HIV-1-infection
Drug: Stable Baseline Regimen
Drug: Bictegravir

Trial sponsors

Gilead Sciences logo
Bristol-Myers Squibb (BMS) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems